Partin Tables
1997
Reference: Partin AW, Kattan MW, Subong EN, et
al. Combination of prostate-specific antigen, clinical stage, and gleason
score to predict pathologic stage of localized prostate cancer. A multi-institutional
update. JAMA 1997; 277:1445-1451.
Instructions
These tables assume that you have no evidence
on x-rays or physical exam of any cancer spread to your bones,
lymph nodes, or seminal vesicles. Look under one of the following four
tables
which
corresponds
to your
initial
PSA
value.
The numbers
at
the intersection
of the Gleason score and the clinical stage are the percentage probabilities
that your cancer is:
- OC - Organ confined
- CP - Capsular penetration
- SV - Seminal vesicle involvement
- LN - Lymph node involvement.
If you do not know your PSA, Gleason score, or
stage ask your physician. Further
explanations are located at the end of this page. Use the most
recent PSA value you had had prior to starting any treatment
or hormonal therapy. Use the highest gleason score (out
of
10) you have had on your most recent pathology report. The staging
system used in these tables is the 1992 AJCC staging system, which
differs slightly from the currently used staging system.
Choose Your PSA Value
PSA 0.0 - 4.0
|
Gleason
|
Clinical Stage |
| T1a |
T1b |
T1c |
T2a |
T2b |
T2c |
T3a |
| 2-4 |
OC
CP
SV
LN |
90
9
0
0 |
80
19
1
0 |
89
10
1
0 |
81
18
1
0 |
72
25
2
0 |
77
21
2
0 |
...
...
...
... |
| 5 |
OC
CP
SV
LN |
82
17
1
0 |
66
32
2
1 |
81
18
1
0 |
68
30
2
0 |
57
40
3
1 |
62
34
3
1 |
40
51
7
2 |
| 6 |
OC
CP
SV
LN |
78
19
1
1 |
61
35
2
2 |
78
21
1
0 |
64
34
2
1 |
52
43
3
2 |
57
37
4
2 |
35
53
7
5 |
| 7 |
OC
CP
SV
LN |
...
...
...
... |
43
44
6
6 |
63
31
4
1 |
47
45
6
2 |
34
51
10
5 |
38
45
12
5 |
19
52
19
9 |
| 8-10 |
OC
CP
SV
LN |
...
...
...
... |
31
43
11
14 |
52
34
9
4 |
36
47
12
5 |
24
48
17
10 |
27
42
21
10 |
...
...
...
... |
PSA 4.1 - 10.0
|
Gleason
|
Clinical
Stage |
| T1a |
T1b |
T1c |
T2a |
T2b |
T2c |
T3a |
| 2-4 |
OC
CP
SV
LN |
84
14
1
0 |
70
27
2
1 |
83
15
1
0 |
71
26
2
0 |
61
35
4
1 |
66
29
5
1 |
43
44
10
1 |
| 5 |
OC
CP
SV
LN |
72
25
2
1 |
53
42
3
2 |
71
27
2
0 |
55
41
3
1 |
43
50
5
2 |
49
43
6
2 |
27
57
12
3 |
| 6 |
OC
CP
SV
LN |
67
27
2
3 |
47
44
3
5 |
67
30
2
1 |
51
44
3
2 |
38
52
5
4 |
43
46
6
4 |
23
57
11
9 |
| 7 |
OC
CP
SV
LN |
49
36
6
8 |
29
48
9
12 |
49
40
8
3 |
33
52
10
4 |
22
54
15
9 |
25
48
18
9 |
11
48
26
15 |
| 8-10 |
OC
CP
SV
LN |
35
34
10
18 |
18
42
15
23 |
37
40
15
8 |
23
49
19
9 |
14
46
24
16 |
15
40
28
17 |
6
34
35
24 |
PSA
10.1 - 20.0
|
Gleason
|
Clinical
Stage |
| T1a |
T1b |
T1c |
T2a |
T2b |
T2c |
T3a |
| 2-4 |
OC
CP
SV
LN |
76
20
2
0 |
58
36
4
2 |
75
22
2
0 |
60
35
4
1 |
48
43
7
1 |
53
37
8
1 |
...
...
...
... |
| 5 |
OC
CP
SV
LN |
61
33
3
3 |
40
50
5
5 |
60
35
3
1 |
43
50
5
2 |
32
57
8
4 |
36
51
9
4 |
18
59
15
17 |
| 6 |
OC
CP
SV
LN |
...
...
...
... |
33
49
4
13 |
55
38
4
3 |
38
52
5
4 |
26
57
7
10 |
31
50
9
10 |
14
54
14
18 |
| 7 |
OC
CP
SV
LN |
33
38
8
18 |
17
46
11
24 |
35
45
12
8 |
22
55
14
9 |
13
51
18
17 |
15
45
22
18 |
6
40
28
26 |
| 8-10 |
OC
CP
SV
LN |
...
...
...
... |
9
33
15
40 |
23
40
20
16 |
14
46
22
17 |
7
38
25
29 |
8
33
30
29 |
3
26
34
37 |
PSA > 20.0
|
Gleason
|
Clinical
Stage |
| T1a |
T1b |
T1c |
T2a |
T2b |
T2c |
T3a |
| 2-4 |
OC
CP
SV
LN |
...
...
...
... |
38
47
9
4 |
58
34
7
1 |
41
48
10
1 |
29
52
14
3 |
...
...
...
... |
...
...
...
... |
| 5 |
OC
CP
SV
LN |
...
...
...
... |
23
57
10
10 |
40
48
9
3 |
26
60
11
3 |
17
61
15
7 |
19
55
19
7 |
8
54
26
11 |
| 6 |
OC
CP
SV
LN |
...
...
...
... |
17
51
8
23 |
35
49
8
7 |
22
60
10
8 |
13
57
13
16 |
15
51
17
17 |
6
46
21
26 |
| 7 |
OC
CP
SV
LN |
...
...
...
... |
...
...
...
... |
18
46
22
14 |
10
51
24
14 |
5
43
27
25 |
6
37
32
25 |
2
29
36
32 |
| 8-10 |
OC
CP
SV
LN |
...
...
...
... |
3
24
20
51 |
10
34
31
24 |
5
37
33
24 |
3
28
33
36 |
3
23
38
35 |
1
17
40
42 |
Further Explanations
These tables were created by doing radical prostatectomies
on thousands of men, and comparing the pathology results with the pre-treatment
PSA, Gleason, and stage. If a prostate cancer is "organ
confined",
this means that it has not broken through the lining of the prostate
gland, has not spread to the seminal vesicles, and has not spread to
the lymph nodes or elsewhere in the body. If a prostate cancer is truly
organ confined, then prostatectomy or a good permanent seed implant
alone will have a high chance of curing the tumor.
If the prostate cancer is no longer organ-confined,
this means that a radical prostatectomy may leave some cancer cells
behind. If any cancer cells are left behind they can multiply and form
a new tumor, and the surgery will have been useless.
If the chance that your cancer is organ-confined
is less than 70%, you may wish to consider therapies which will also
treat the tissues around the prostate gland, such as external beam
radiation.
The numbers listed in the tables are only statistical
estimates. The chance of having prostate cancer breaking through the
capsule can also be influenced by risk
factors other than the stage, grade, and PSA.
|